Overview
Giovanna Polcaro practices practicing medicine in Baronissi, Italy.
Her clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, and Melanoma.
She is actively involved in clinical research, co-authoring 21 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Giovanna Polcaro
Is Giovanna Polcaro a top-rated expert for Non-Small Cell Lung Cancer (NSCLC)?
MediFind is an objective health platform that identifies experts based on real-world data. Giovanna Polcaro is classified as an Experienced expert for Non-Small Cell Lung Cancer (NSCLC), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Giovanna Polcaro participate in research or clinical trials?
Yes. Giovanna Polcaro has published 21 articles and abstracts on conditions like Non-Small Cell Lung Cancer (NSCLC). You can view a list of Giovanna Polcaro's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Lung CancerMs. Polcaro isExperienced. Learn about Lung Cancer.
- MelanomaMs. Polcaro isExperienced. Learn about Melanoma.
- Non-Small Cell Lung Cancer (NSCLC)Ms. Polcaro isExperienced. Learn about Non-Small Cell Lung Cancer (NSCLC).